Loading...
Active Trial
Malaria vaccine
Sponsor
Pharma B
Expected Enrollment
200
Duration
10 mths
Protocol
v2.1
Status
Closed
A multicenter, randomized, double-blind study evaluating the safety, immunogenicity, and efficacy of a malaria vaccine candidate in preventing Plasmodium falciparum infection among healthy patients.
Compliance note
Accepting this invitation will add this trial to your site and move it into the setup phase. You'll then be able to configure your site before enrolling patients.
Facilities Needed
Staff Allocation
Invitation received
Sponsor Profile
Pharma B (Roche)
Department of malariology